Most clinicians who offer cosmetic treatment will have met a patient whose concern about a feature seemed out of proportion to what they could see, or who returned repeatedly, dissatisfied with results that looked good. Until now the national guidance on what to do about that has been brief and rarely read outside mental health services. In September 2026 the National Institute for Health and Care Excellence (NICE) published a draft guideline that addresses cosmetic practice directly. It sets out the questions to ask, says the answers should be recorded, and recommends that treatment should not go ahead where the answers suggest body dysmorphic disorder.
This article explains what the draft says, how it relates to the existing guidance and to the law on consent, and how a clinic can build BDD screening into its consultation and its records. It is written for every regulated professional who provides cosmetic procedures: aesthetic doctors, nurses and pharmacist prescribers, dentists and dental care professionals offering facial or smile treatments, cosmetic and oculoplastic surgeons, dermatologists, and the clinic owners and managers who set the consultation process.
What has NICE proposed on BDD screening before cosmetic procedures?
The draft guideline, Obsessive compulsive disorder and body dysmorphic disorder: assessment and management, will partially update NICE guideline CG31, which was published in November 2005. On its first page the draft lists who it is for, and the first group named is healthcare professionals, "including those who provide cosmetic procedures (surgeons, doctors, dentists, dental care professionals, nurses or pharmacists)". The NICE project page records a draft guidance consultation from 17 September 2026 to 21 October 2026 and an expected publication date of 16 February 2027.
Three groups of recommendations matter most for cosmetic practice. Recommendation 1.5.5 lists people who may be at higher risk of OCD or BDD and in whom assessment should be considered. The list includes people with depression or anxiety, an eating disorder or a history of OCD or BDD, people with autism or ADHD, and people seeking "a cosmetic procedure (including dermatological or dental)". Recommendation 1.7.1 then sets out the assessment questions. Recommendations 1.7.4 to 1.7.6, under the heading "Assessing for BDD before cosmetic procedures", say what cosmetic providers should do with them.
Who does the draft apply to?
The draft defines cosmetic procedures as surgical or non-surgical procedures, including aesthetic ones, "undertaken primarily to alter appearance rather than for the treatment of disease, disorder or injury". It then limits the term to interventions provided by regulated healthcare professionals: surgeons, doctors, dentists, dental care professionals, nurses or pharmacists.
That definition is wider than the injectables market. It takes in cosmetic surgery, including cosmetic eyelid and brow surgery, where functional and cosmetic indications can overlap and our guide to blepharoplasty consent already recommends recording the patient's motivation. It takes in dermatologists and skin clinics offering laser and peels, and dentists offering veneers, whitening or facial treatments, since recommendation 1.5.5 refers expressly to dermatological and dental cosmetic procedures. GPs and private doctors who add aesthetic sessions to their practice, and pharmacist and nurse prescribers who assess patients for toxin or filler, are also within it. Non-healthcare practitioners fall outside the definition, but clinics that employ them under a prescriber's oversight will want a single process for everyone who sees patients.
16 Feb 2027
is the expected publication date of the final NICE guideline on OCD and BDD, according to the NICE project page. Until then the recommendations are a draft that may change after the consultation that closed on 21 October 2026.
What questions does NICE suggest asking?
Recommendation 1.7.1 lists the assessment questions. In summary, the draft suggests asking whether the person worries a lot about their appearance or is preoccupied with it and wishes they could think about it less; what their specific concerns are; how long on a typical day they think about their appearance (the draft gives more than 1 hour as an example); how much time they spend checking or comparing their appearance with others, including online; and how much time they spend trying to change, hide or conceal it. It then asks what effect these thoughts have on the person's life, giving repeated avoidance of social situations, checking in reflective surfaces and comparing themselves with others as examples, and whether the thoughts get in the way of work, friends or activities or cause distress.
Recommendation 1.5.2 adds an observational element. Where BDD is suspected, the draft asks professionals to look for visual cues that may suggest a person is trying to conceal or alter their appearance, such as clothing that seems unusual for the context or covering the face.
These questions build on the five questions in CG31, which have been in place since 2005. Some screening tools are already used in cosmetic practice. A March 2023 guidance paper for registrants of the Joint Council for Cosmetic Practitioners (JCCP), which is marked as a draft, lists the Appearance Anxiety Inventory, the Cosmetic Procedures Screening Questionnaire (COPS), the Body Dysmorphic Disorder Questionnaire (BDDQ), the BDD modification of the Y-BOCS and FACE-Q. NICE's draft does not require a particular tool. What it does require is that the questions are asked and the findings documented.
Interactive tool
How close is your consultation to the NICE draft?
Tick each statement that is true of your clinic today. Nothing you select is sent anywhere.
Should you decline treatment if a patient screens positive for BDD?
The draft is direct on this point. Recommendation 1.7.6 says that if a person's responses to the assessment questions indicate they may have BDD, the healthcare professional should not carry out the procedure, should explain the decision not to carry it out "in a sensitive and supportive way" and discuss any concerns the person may have, and should refer the person to a healthcare professional with expertise in BDD in line with agreed referral pathways.
The committee's reasoning is set out in the rationale. It agreed that if BDD is suspected, professionals should not perform the procedure "because it may reinforce or worsen BDD-related distress and behaviours". Recommendation 1.7.2 makes the related point for anyone with suspected or confirmed BDD who mentions interest in a cosmetic procedure: discuss their expectations, and explain that cosmetic procedures rarely improve BDD symptoms and may sometimes worsen them.
The draft also addresses how the conversation should be held. Recommendation 1.7.3 says that when a person with suspected or confirmed BDD explains how they think and feel about their appearance, professionals should treat the response with empathy and should not comment, positively or negatively, on their appearance, or directly challenge their perception. The committee explained that comments on appearance "can feel dismissive or disingenuous". For a clinician whose instinct is to reassure a patient that a feature looks normal, this is a practical change in how the consultation is run.
Common assumptions
Tap each card to compare the assumption with what the draft says.
How does this fit with the existing guidance and with consent law?
The draft is not the first national guidance on this subject. CG31 recommends that for people at higher risk of BDD, including "people with mild disfigurements or blemishes who are seeking a cosmetic or dermatological procedure", healthcare professionals should routinely consider and explore the possibility of BDD. It sets out five assessment questions, and recommendation 1.4.2.3 says people with suspected or diagnosed BDD seeking cosmetic surgery or dermatological treatment should be assessed by a mental health professional with specific expertise in BDD. Recommendation 1.4.2.6 asks specialist BDD services to work with cosmetic surgeons and dermatologists on an agreed screening system and referral criteria. The new draft extends this to all regulated cosmetic providers, makes asking and documenting a routine step, and says plainly that the procedure should not go ahead.
The government's licensing work has picked up the same theme. In its consultation response on the licensing of non-surgical cosmetic procedures in England, published on 7 August 2025, the Department of Health and Social Care reported that several responses cited concerns about psychological vulnerabilities, including body dysmorphia, and that some respondents suggested an assessment of psychological wellbeing, including motivation and expectations, "should be a central part of the pre-procedure consultation process". We set out where that scheme has reached in our licensing scheme timeline.
Screening also sits within the law on consent. In Montgomery v Lanarkshire Health Board [2015] UKSC 11 the Supreme Court held, at paragraph 87, that the doctor must take reasonable care to ensure the patient is aware of any material risks of the recommended treatment and of any reasonable alternative or variant treatments, and that materiality includes risks "the doctor is or should reasonably be aware that the particular patient would be likely to attach significance to". In McCulloch v Forth Valley Health Board [2023] UKSC 26 the court confirmed at paragraph 58 that the duty is to inform the patient of all reasonable treatment options, which we explain in our note on reasonable alternatives. For a patient whose motivation is appearance-related distress, the draft's statement that cosmetic procedures rarely improve BDD symptoms and may worsen them is plainly information a reasonable patient would want, and no treatment is a reasonable option to discuss. Whether a particular failure to screen would amount to negligence is a question for the courts on the facts, and this article does not suggest an answer to it.
What should the record show?
The committee said professionals should record their findings "to support consistent decision-making and audits". In practice, a note that says only "BDD screen negative" tells a later reader very little. A useful record shows which questions were asked, the patient's answers in their own words where possible, the patient's stated expectations of the procedure, the clinician's assessment, and the decision taken. Where treatment is declined, it should record the explanation given, the patient's response, and the referral or signposting offered. Our article on aesthetic consultation notes sets out a line-by-line standard that this fits into, and the consent process page explains how screening sits alongside information-giving and time for reflection.
The record also matters when a patient is dissatisfied. A clear note of appearance concerns and expectations taken before treatment is often the most useful document when a complaint arrives, and our guide to responding to a patient complaint explains why notes must never be altered afterwards. If a complaint, claim or regulatory matter is already live, take advice from your indemnity provider or a solicitor before responding.
Check your understanding
A patient asks for lip filler. During the consultation she says she thinks about her lips for several hours a day, checks them in every reflective surface and has stopped seeing friends. Under the NICE draft, what should the practitioner do?
Her answers match several of the assessment questions in recommendation 1.7.1, including time spent thinking about appearance, checking, and effects on social life. Recommendation 1.7.6 says that where the answers indicate possible BDD the professional should not carry out the procedure, should explain the decision in a sensitive and supportive way, and should refer. Recommendation 1.7.3 advises against commenting on appearance, and a cooling-off period does not address possible BDD.
How to build BDD screening into your clinic
- Add the questions to your consultation template. Use the questions in recommendation 1.7.1, or a recognised tool that covers the same ground, and leave space to record the answers rather than a single tick box.
- Ask every new cosmetic patient. Recommendation 1.7.5 refers to the people seeking your services, not only those who appear anxious. Review the answers when a patient returns for a different or more invasive procedure.
- Record expectations in the patient's words. Recommendation 1.7.2 asks you to discuss expectations. A short quotation of what the patient hopes the treatment will change is more useful than a summary.
- Write a process for declining treatment. Decide who makes the decision, how it is explained, what written information is given, and how the conversation is documented. Make sure any deposit or booking policy does not discourage clinicians from declining.
- Agree a referral route. Recommendation 1.7.4 asks cosmetic providers to work with BDD specialists on local referral pathways. At minimum, know how you will refer through the patient's GP and record that you did so.
- Train the team. Everyone who consults, including non-prescribing practitioners working under your oversight, should know the questions, the cues in recommendation 1.5.2, and the advice not to comment on appearance.
- Audit. Check a sample of records each quarter to see whether screening is being done and recorded. The consent and records audit can do this independently, and the Readiness Score gives a quick view of wider governance gaps.
These steps are consistent with both CG31 and the draft, so a clinic that adopts them now should need only minor changes when the final guideline is published. Wider consent requirements for aesthetic work, including time for reflection, are covered in our complete guide to consent in aesthetic practice and our article on cooling-off periods. Specialty guidance for injectables is on our medical aesthetics page.
Frequently asked questions
NICE guidelines are not legislation. The September 2026 recommendations are a draft, and the final guideline is expected on 16 February 2027. The existing guideline, CG31, already asks professionals to consider BDD in people seeking cosmetic or dermatological procedures, so structured screening reflects current national guidance as well as the draft.
It covers healthcare professionals who provide cosmetic procedures, which the draft lists as surgeons, doctors, dentists, dental care professionals, nurses and pharmacists. It defines cosmetic procedures as surgical or non-surgical procedures undertaken primarily to alter appearance rather than to treat disease, disorder or injury.
Recommendation 1.7.1 of the draft asks about preoccupation with appearance, specific concerns, time spent thinking about appearance on a typical day, time spent checking, comparing or concealing, and the effect on daily life, work and relationships. Recognised tools such as the BDDQ or COPS cover similar ground.
The draft asks professionals to explain the decision in a sensitive and supportive way, discuss the person's concerns, avoid commenting on their appearance or challenging their perception, and refer them to a professional with expertise in BDD. Record the explanation, the patient's response and the referral.
Yes. Recommendation 1.5.5 lists people seeking a cosmetic procedure, including dermatological or dental procedures, among those in whom assessment for OCD or BDD should be considered, and dentists and dental care professionals are named in the draft's audience.
Sources
- National Institute for Health and Care Excellence. Obsessive compulsive disorder and body dysmorphic disorder: assessment and management. Draft for consultation, September 2026, recommendations 1.3.1, 1.5.2, 1.5.5, 1.7.1 to 1.7.6, rationales and terms used.
- National Institute for Health and Care Excellence. Obsessive-compulsive disorder and body dysmorphic disorder: assessment and management, project information (GID-NG10435), including consultation dates and expected publication date.
- National Institute for Health and Care Excellence. Obsessive-compulsive disorder and body dysmorphic disorder: treatment (CG31), Recommendations, recommendations 1.4.2.1 to 1.4.2.6.
- Joint Council for Cosmetic Practitioners. Guidance paper for JCCP Registrants: Patient Emotional and Psychological Safety, March 2023 (marked draft).
- Department of Health and Social Care. The licensing of non-surgical cosmetic procedures in England: consultation response, 7 August 2025.
- Montgomery v Lanarkshire Health Board [2015] UKSC 11, judgment, paragraph 87, The National Archives, Find Case Law.
- McCulloch and others v Forth Valley Health Board [2023] UKSC 26, judgment, paragraphs 57 and 58, The National Archives, Find Case Law.
Filed under: Consent · Aesthetics · Dentistry · Governance



